Add BrightSurf on Google Email

Effectiveness associated with Pfizer/BioNTech vaccine against emergency department, urgent care encounters for SARS-CoV-2 infection among adolescents

The Pfizer/BioNTech COVID-19 vaccine demonstrated high levels of protection against emergency department and urgent care encounters related to Delta and Omicron variants. A third dose improved protection against Omicron beyond initial two-dose efficacy, emphasizing the importance of boosters for adolescents aged 12-17.

SourceJAMA Network·JournalJAMA Network Open·DateAug 3, 2022

SARS-CoV-2 and vaccine uptake among First Nations, Inuit and Métis Peoples in urban areas

A new study published in the Canadian Medical Association Journal found that vaccine uptake was low among First Nations, Inuit and Métis Peoples in Toronto and London, Ontario. The rate for 2-dose vaccination among First Nations, Inuit and Métis in Toronto was 58%, compared to 79% for the overall population.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·TypeObservational study·DateAug 2, 2022

Association of state COVID-19 vaccine mandates with staff vaccination coverage, staffing shortages in nursing homes

A study of nursing homes found that states with vaccine mandates had higher staff vaccination rates and fewer staffing shortages compared to those without mandates. This suggests that vaccine mandates can lead to improved vaccination coverage among healthcare workers, reducing the risk of COVID-19 outbreaks in long-term care facilities.

SourceJAMA Network·JournalJAMA Health Forum·DateJul 29, 2022

Meningref trial shows better protection against meningococcal infection in hematopoietic stem cell transplant recipients

Researchers studied the immunogenic potential of the 4CMenB vaccine in hematopoietic stem cell transplant recipients, finding 90% of patients developed protective antibody levels after two doses. The trial supports including meningococcal B vaccination alongside A, C, W, and Y vaccines from 6 months post-transplant to improve protection.

SourceInstitut Pasteur·JournalClinical Microbiology and Infection·DateJul 29, 2022

In early COVID-19 vaccine roll-out, health facilities in US metropolitan areas with a high proportion of Black citizens were less likely to administer immunizations – indicating a possible vaccine access barrier

A US study found that health facilities in metropolitan areas with a high proportion of Black citizens were less likely to administer COVID-19 vaccines, indicating potential vaccine access barriers. The study suggests disparities in vaccine distribution across the country.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateJul 28, 2022

Public health researchers develop web-based guide to help family physicians address COVID-19 vaccine hesitancy

Public health researchers developed an interactive web-based guide to support family physicians in addressing COVID-19 vaccine concerns. The guide provides resources to counsel patients on safety, co-morbidities, conspiracy theories, and other issues, promoting better conversations and vaccine uptake.

SourceAmerican Academy of Family Physicians·JournalThe Annals of Family Medicine·DateJul 26, 2022

New fast test discriminates between cellular immunity to SARS-CoV-2 after vaccination or infection

Researchers developed a new blood test that can indicate cellular immunity to SARS-CoV-2 within 48 hours. The test distinguishes between post-infection and post-vaccination immunity, enabling quick diagnosis for patients unable to produce antibodies. Long-lasting T-cell responses may protect against severe disease in re-infections.

SourceMedical University of Vienna·JournalAllergy·DateJul 20, 2022

Study identifies barriers to COVID-19 vaccine uptake and the powerful influence of family and friends

A study found that COVID-19 vaccination rates are driven more by perceptions of others' intentions than public health messaging. Family and friends have a stronger influence on vaccination decisions, while public health efforts targeting broader groups may be less effective.

SourceBrown University·JournalProceedings of the National Academy of Sciences·TypeData/statistical analysis·DateJul 20, 2022

Booster shots offset some of Omicron immune evasion tactics

A new study suggests that current vaccine boosters intensify protections against serious infection caused by Omicron subvariants. The research found that booster doses bring neutralizing antibodies to appreciable levels against all Omicron subvariants, consistent with other evidence of expanded memory B cells and antibody production.

SourceUniversity of Washington School of Medicine/UW Medicine·JournalScience·TypeExperimental study·DateJul 19, 2022

IVI kicks off first ‘Introductory Course for Biologics Development and Manufacturing’ to train 117 people from 25 LMICs on July 18

The International Vaccine Institute (IVI) has launched a two-week training course for biologics development and manufacturing, targeting low- and middle-income countries. The program aims to enhance local production of vaccines and biologics in LMICs to address vaccine inequity and global pandemic preparedness.

Scientists identify what makes the Delta variant dangerous and explain the recent surge in COVID-19 infections

Researchers analyze delta variant's biophysical characteristics, revealing unique traits that evade neutralizing antibodies and contribute to severe symptoms. The study sheds light on why vaccinated individuals can still contract the virus and why delta variant hospitalizations are higher than other variants.

SourceUniversity of Colorado Anschutz Medical Campus·JournalJournal of Molecular Biology·DateJul 18, 2022

Poxvirus proteins enable early strike on immune defences

A new study identifies pox virus proteins that directly interfere with the body's innate immune system, allowing it to evade the host's defense mechanisms. The research team has discovered five 'redox' proteins that interact with Reactive Oxygen Species, which play a key role in destroying pathogens identified by the immune system.

SourceUniversity of Birmingham·JournalPLOS Pathogens·TypeExperimental study·DateJul 14, 2022

Scientists at the University of Malaga inquire into the biogeography of yellow fever transmission

Researchers at the University of Malaga study the global risk of yellow fever transmission to humans, finding high zoonotic potential in southeastern Brazil and western Amazon basin. The team proposes prioritizing vaccination efforts in regions with favorable conditions for virus presence and mosquito vectors.

SourceUniversity of Malaga·JournalCommunications Biology·TypeMeta-analysis·DateJul 12, 2022

Coin-sized device detects measles virus in saliva

A novel point-of-care biosensing device has been developed to detect measles virions in human saliva, potentially aiding in viral spread control. The device, smaller than a €1-cent coin or U.S. quarter, utilizes lab-on-a-chip technology and showed high accuracy in experiments.

SourceWiley·JournalAdvanced Functional Materials·DateJul 7, 2022

Age may rival politics in COVID-19 vaccine debate

A new study from the University of Georgia suggests that age and risk perception have a significant impact on COVID-19 vaccine acceptance, surpassing political ideology. Older adults (50+) are more likely to consider themselves at risk for severe illness and are universally vaccinated, particularly above 75 years old.

SourceUniversity of Georgia·JournalInternational Journal of Strategic Communication·DateJul 5, 2022

Emerging Omicron subvariants BA.2.12.1, BA.4 and BA.5 are inhibited less efficiently by antibodies

Researchers at the German Primate Center found that emerging Omicron subvariants BA.2.12.1, BA.4, and BA.5 are inhibited less efficiently by existing therapeutic antibodies, which may reduce protection against future infections. The study suggests these variants have acquired biological traits allowing for more efficient transmission.

SourceDeutsches Primatenzentrum (DPZ)/German Primate Center·JournalThe Lancet Infectious Diseases·TypeExperimental study·DateJul 1, 2022

Large study on the effectiveness of the Pfizer Covid-19 vaccine in children aged 5-11 published in The New England Journal of Medicine

A large study found moderate protection against SARS-CoV-2 infection and symptomatic Covid-19 illness among vaccinated children, with greater protection observed in younger age subgroups. The research used Israel's Clalit Health Services database to control for confounding variables.

SourceClalit Research Institute·JournalNew England Journal of Medicine·TypeData/statistical analysis·DateJun 29, 2022

New technique for detecting typhoid infections faster, more accurate than conventional testing, according to study

A new technique for detecting typhoidal Salmonella infections has been developed, allowing for faster and more accurate tracking of infections, particularly in rural areas. The approach detects typhoid antibodies in dried blood spots, providing valuable information for vaccination planning and disease surveillance.

SourceUniversity of California - Davis Health·JournalThe Lancet Microbe·DateJun 28, 2022

Canada's COVID-19 response in first 2 years of pandemic compares well with other countries' measures

A comparison analysis found that Canada handled the pandemic well by most measures, thanks to strict policies and high vaccination rates. The analysis showed that if US vaccination and death rates occurred in Canada, about 5.9 million fewer Canadians would have been vaccinated and 68,800 more would have died from COVID-19.

SourceCanadian Medical Association Journal·JournalCanadian Medical Association Journal·DateJun 27, 2022

Newer COVID-19 subvariants are less vulnerable to immunity induced by vaccination and previous infection, researchers find

Researchers at Beth Israel Deaconess Medical Center found that newer Omicron subvariants BA.4 and BA.5 escape neutralizing antibodies induced by both vaccination and previous infection. These variants are now responsible for over 21% of new cases in the US, highlighting a shift in the COVID-19 landscape.

SourceBeth Israel Deaconess Medical Center·JournalNew England Journal of Medicine·DateJun 23, 2022

Association of receipt of fourth Pfizer-BioNTech vaccine dose with Omicron infection, COVID-19 hospitalizations among residents of long-term care facilities

A fourth dose of the Pfizer-BioNTech vaccine provided high protection against severe outcomes from Omicron infection among elderly residents in Israeli long-term care facilities. The vaccine also offered modest protection against COVID-19 infections among this population during a surge in Omicron variant cases.

SourceJAMA Network·JournalJAMA Internal Medicine·DateJun 23, 2022

New study finds COVID-19 booster increases antibodies by more than 85% in nursing home residents and their caregivers

A new study found that COVID-19 booster shots significantly increase neutralizing antibodies in nursing home residents and their caregivers, offering improved protection against Omicron variants. This research highlights the importance of booster vaccinations for vulnerable populations, including those living at home.

SourceCase Western Reserve University·JournalEBioMedicine·DateJun 22, 2022